He will also be the President and General Manager of Glenmark's Switzerland-based business units. He will lead the company's global research portfolio consisting of NBE, NCE, generics and branded formulations, Glenmark Pharmaceuticals said in a statement.
Stoeckli will be responsible for sustaining and enhancing the environment of collaborative research and for driving successful commercialisation of Glenmark's research pipeline in partnership with other leaders, it added.
He joins the company from Sanofi where he was Group Vice President, Global Biopharmaceuticals Division and Chief Scientific Officer for Research and Development France, Glenmark Pharmaceuticals said in a statement. Stoeckli will report to Glenn Saldanha and will be based out of Neuchactel, Switzerland.
(This story has not been edited by NDTV staff and is auto-generated from a syndicated feed.)